{"_links":{"self":[{"href":"/project/GID-HST10009"}]},"_embedded":{"nice.indev:timeline-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:timeline":[{"_links":{"self":[{}]},"ETag":null,"Column1":"06 July 2022","Column2":"Committee meeting: 4","AdditionalInfoLabel":"Meeting number","AdditionalInfo":"4","Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"08 February 2022","Column2":"Stakeholder workshop","AdditionalInfoLabel":"Location of meeting","AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"04 June 2020","Column2":"Following the announcement that will be planning a phased restart of paused guidance from 01 June, NICE will be planning a virtual stakeholder engagement workshop for this topic. The date of the workshop along with further timelines are TBC.","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"05 May 2020","Column2":"Schedule affected by COVID-19. Topic update: this evaluation has not been defined as therapeutically critical. The appraisal was therefore  paused as part of the impact experienced by COVID-19. \r\n\r\nA committee meeting has been scheduled for the 06 July to discuss this topic.","AdditionalInfoLabel":"Link text","AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"14 March 2019","Column2":"Committee meeting: 3","AdditionalInfoLabel":"Meeting number","AdditionalInfo":"3","Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"09 October 2018","Column2":"Appeal decision","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"20 June 2018","Column2":"Appeal","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"22 May 2018 - 06 June 2018","Column2":"Final evaluation determination","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"20 February 2018","Column2":"Committee meeting: 2","AdditionalInfoLabel":"Meeting number","AdditionalInfo":"2","Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"20 December 2017 - 24 January 2018","Column2":"Evaluation consultation: 1","AdditionalInfoLabel":null,"AdditionalInfo":"1","Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"23 November 2017","Column2":"Committee meeting: 1","AdditionalInfoLabel":"Meeting number","AdditionalInfo":"1","Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"28 July 2017","Column2":"Following an update from the company, the first committee meeting for this topic has been rescheduled to allow for an extension to the submission deadline. The first committee meeting will now take place on 23 November 2017. Please note the dates for the second committee meeting and planned publication are unchanged.","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"17 May 2017","Column2":"Invitation to participate","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"17 May 2017","Column2":"In progress. Topic in evaluation","AdditionalInfoLabel":"Link text","AdditionalInfo":null,"Hidden":false},{"_links":{"self":[{}]},"ETag":null,"Column1":"21 April 2017","Column2":"Referral","AdditionalInfoLabel":null,"AdditionalInfo":null,"Hidden":false}]},"ETag":null},"nice.indev:process-homepage":{"_links":{"self":[{"href":"https://www.nice.org.uk/process/pmg20/chapter/introduction"},{}]},"ETag":null,"Description":"For further information on our processes and methods, please see our","LinkText":"CHTE processes and methods manual default"},"nice.indev:project-team-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:project-team":{"_links":{"self":[{}]},"ETag":null,"Column1":"Project lead","Column2":"Daniel Davies"}},"ETag":null},"nice.indev:email-enquiry-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:email-enquiry":{"_links":{"self":[{}]},"ETag":null,"Item":"hst@nice.org.uk"}},"ETag":null},"nice.indev:consultee-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:consultee":[{"_links":{"self":[{}]},"ETag":null,"Column1":"Companies sponsors","Column2":"Clinuvel UK "},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"Department of Health"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"NHS England"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Others","Column2":"Welsh Government"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"British Porphyria Association"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Patient carer groups","Column2":"International Porphyria Patients Network"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"British Association of Dermatologists"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"Royal College of Pathologists"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"Royal College of Physicians"},{"_links":{"self":[{}]},"ETag":null,"Column1":"Professional groups","Column2":"Mark Holland Metabolic Unit (Salford Royal NHS Foundation Trust)"}]},"ETag":null},"nice.indev:commentator-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:commentator":[{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"All Wales Therapeutics and Toxicology Centre"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"British National Formulary"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"Department of Health, Social Services and Public Safety for Northern Ireland"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"Healthcare Improvement Scotland"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"Scottish Medicines Consortium"},{"_links":{"self":[{}]},"ETag":null,"Column1":"General commentators","Column2":"Welsh Health Specialised Services Committee"}]},"ETag":null},"nice.indev:panel-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:panel":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/html-content-3"}]},"ETag":null,"Id":"5f2cf4e8-b525-4f5c-aa4f-d3a948096dc5","MimeType":"text/html","FileName":"HtmlContent","Length":1971,"Hash":"077321A8A83D022E6E5D062DCB3ABFD7C39F1B00","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"html-content-3","ConsultationDocumentId":0}},"ETag":null,"Title":"Appeal","Level":1,"PublishedDate":"2018-06-20T08:55:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/appeal-letter"}]},"ETag":null,"Id":"714fc856-2cde-40ea-a264-c4ba7d1396f7","MimeType":"application/pdf","FileName":"appeal-porphyria-CLINUVEL.pdf","Length":758234,"Hash":"C2BB45A1AF585C60C72B4D423E52FC3CD3996914","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"appeal-letter","ConsultationDocumentId":0}},"ETag":null,"Title":"CLINUVEL (UK) LTD : Appeal letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/scrutiny-letter"}]},"ETag":null,"Id":"c276ac99-43e9-48b8-9437-ca1275117def","MimeType":"application/pdf","FileName":"initial-scrutiny-porphyria-CLINUVEL.pdf","Length":287896,"Hash":"3178DC155582178D92BC4AFC95553AE2AA5A4D55","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"scrutiny-letter","ConsultationDocumentId":0}},"ETag":null,"Title":"CLINUVEL (UK) LTD : Scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/response-to-scrutiny-letter"}]},"ETag":null,"Id":"0d2885ab-2bfe-45e4-b178-3a8dc08f97e5","MimeType":"application/pdf","FileName":"response-to-initial-scrutiny-porphyria-CLINUVEL.pdf","Length":449722,"Hash":"54E72C017B55F06CCDF2C90E4AC3DDE85547CD7C","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"response-to-scrutiny-letter","ConsultationDocumentId":0}},"ETag":null,"Title":"CLINUVEL (UK) LTD : Response to scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-scrutiny-letter"}]},"ETag":null,"Id":"75ea704d-52b9-4111-aa9e-774408c1ba81","MimeType":"application/pdf","FileName":"final-scrutiny-porphyria-CLINUVEL.pdf","Length":172057,"Hash":"81C1F2ED5AAA6FEB9B46D402AE200958838DA004","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-scrutiny-letter","ConsultationDocumentId":0}},"ETag":null,"Title":"CLINUVEL (UK) LTD : Final scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/appeal-letter-2"}]},"ETag":null,"Id":"39a88ca7-b28c-4259-9a98-baf386580e3b","MimeType":"application/pdf","FileName":"appeal-porphyria-IPPN.pdf","Length":1172705,"Hash":"CD15E3D14AB64767D338513007AD309FDDA45089","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"appeal-letter-2","ConsultationDocumentId":0}},"ETag":null,"Title":"International Porphyria Patient Network : Appeal letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/scrutiny-letter-2"}]},"ETag":null,"Id":"1b1e13c8-d123-459d-abca-767d6294de16","MimeType":"application/pdf","FileName":"initial-scrutiny-porphyria-IPPN.pdf","Length":275977,"Hash":"F45173942D26F1C09FB79145700F7CDD310307FA","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"scrutiny-letter-2","ConsultationDocumentId":0}},"ETag":null,"Title":"International Porphyria Patient Network : Scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/response-to-scrutiny-letter-2"}]},"ETag":null,"Id":"f8163780-392a-4091-a8d7-21670dc706ba","MimeType":"application/pdf","FileName":"response-to-initial-scrutiny-porphyria-IPPN.pdf","Length":426490,"Hash":"57EE895D84483E323F46712BAC8780FB1767E267","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"response-to-scrutiny-letter-2","ConsultationDocumentId":0}},"ETag":null,"Title":"International Porphyria Patient Network : Response to scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-scrutiny-letter-2"}]},"ETag":null,"Id":"c54aa4d6-7740-4db9-8971-eab7c6097cd7","MimeType":"application/pdf","FileName":"final-scrutiny-porphyria-IPPN.pdf","Length":197908,"Hash":"002797E2618E63C44CFC54B48D91DA43B878E95E","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-scrutiny-letter-2","ConsultationDocumentId":0}},"ETag":null,"Title":"International Porphyria Patient Network : Final scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/appeal-letter-3"}]},"ETag":null,"Id":"ad0fc884-22fa-4fc1-8c23-b2bbee73793b","MimeType":"application/pdf","FileName":"appeal-porphyria-BPA.pdf","Length":300410,"Hash":"0FED61A6FE302A3D0DE0E220BCFDF57D8E162CBE","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"appeal-letter-3","ConsultationDocumentId":0}},"ETag":null,"Title":"British Porphyria Association : Appeal letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/scrutiny-letter-3"}]},"ETag":null,"Id":"b42231a3-7fc4-40b4-8b95-db75d88c9634","MimeType":"application/pdf","FileName":"initial-scrutiny-porphyria-BPA.pdf","Length":138178,"Hash":"0070F6012FB26C5206F99243DFB36E15DB1D65C8","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"scrutiny-letter-3","ConsultationDocumentId":0}},"ETag":null,"Title":"British Porphyria Association : Scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/response-to-scrutiny-letter-3"}]},"ETag":null,"Id":"426a4385-6039-4567-9caf-1f4c042d5d0b","MimeType":"application/pdf","FileName":"response-to-initial-scrutiny-porphyria-BPA.pdf","Length":95367,"Hash":"2033A2D16E2CF0FE8D8D9E7E694CB710D2C61990","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"response-to-scrutiny-letter-3","ConsultationDocumentId":0}},"ETag":null,"Title":"British Porphyria Association : Response to scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-scrutiny-letter-3"}]},"ETag":null,"Id":"80ce3c86-de1f-4eb2-bb44-99a66c5770f3","MimeType":"application/pdf","FileName":"final-scrutiny-porphyria-BPA.pdf","Length":61798,"Hash":"446837359F33E9BC9DF233BD7BEE2D11B0D44C48","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-scrutiny-letter-3","ConsultationDocumentId":0}},"ETag":null,"Title":"British Porphyria Association : Final scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/appeal-letter-4"}]},"ETag":null,"Id":"1eae36c7-1750-4c4a-95ee-16c6b2d4d61b","MimeType":"application/pdf","FileName":"appeal-porphyria-BAD.pdf","Length":312099,"Hash":"86990790186955A124B6516BF6D3BB91781CC9E8","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"appeal-letter-4","ConsultationDocumentId":0}},"ETag":null,"Title":"British Association of Dermatologists : Appeal letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/scrutiny-letter-4"}]},"ETag":null,"Id":"b51a97dd-54a3-411b-ac05-0a19d41059d3","MimeType":"application/pdf","FileName":"initial-scrutiny-porphyria-BAD.pdf","Length":149791,"Hash":"E7F9F626731318A371E209B4CB78EEAF6D527480","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"scrutiny-letter-4","ConsultationDocumentId":0}},"ETag":null,"Title":"British Association of Dermatologists : Scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/response-to-scrutiny-letter-4"}]},"ETag":null,"Id":"1c0d1135-44e0-43cc-a1ca-22a4e11f532d","MimeType":"application/pdf","FileName":"response-to-initial-scrutiny-porphyria-BAD.pdf","Length":59003,"Hash":"7899CDD89253EAA0CE5526F6817DF8CE3AEBD271","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"response-to-scrutiny-letter-4","ConsultationDocumentId":0}},"ETag":null,"Title":"British Association of Dermatologists : Response to scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-scrutiny-letter-4"}]},"ETag":null,"Id":"ddbaff4f-5b4c-4e17-8369-d490e56f8ebb","MimeType":"application/pdf","FileName":"final-scrutiny-porphyria-BAD.pdf","Length":43588,"Hash":"AA14554BD7CE7FF70A22FBCE486EE1CB3D51B868","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-scrutiny-letter-4","ConsultationDocumentId":0}},"ETag":null,"Title":"British Association of Dermatologists : Final scrutiny letter","Level":2,"PublishedDate":"2018-07-30T10:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/appeal-decision"}]},"ETag":null,"Id":"871bd67e-d8fe-4db4-997a-f0e64c9bb9e2","MimeType":"application/pdf","FileName":"appeal-decision-afamelanotideID927.pdf","Length":580242,"Hash":"89940918DB47B80FD8E1EC509196B4F10BA617CA","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"appeal-decision","ConsultationDocumentId":0}},"ETag":null,"Title":"Appeal decision","Level":1,"PublishedDate":"2018-10-09T01:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Appeal","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/html-content-2"}]},"ETag":null,"Id":"b4a5cd73-6eae-41ab-a3c8-117499b6ecbb","MimeType":"text/html","FileName":"HtmlContent","Length":810,"Hash":"42687A62A562456AC482782C4014BD6593B8DA67","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"html-content-2","ConsultationDocumentId":0}},"ETag":null,"Title":"Final evaluation determination","Level":1,"PublishedDate":"2018-05-22T00:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":104,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/committee-papers-2"}]},"ETag":null,"Id":"c30e1a23-7e2d-46bf-b82b-ba37fa69041c","MimeType":"application/pdf","FileName":"ID927 afamelanotide_FED_CmtePprs.pdf","Length":5259175,"Hash":"5BED000E54AA369CAD24693F3E272E0674C6F9BD","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"committee-papers-2","ConsultationDocumentId":0}},"ETag":null,"Title":"Committee papers","Level":1,"PublishedDate":"2018-05-22T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":104,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/1-2"}]},"ETag":null,"Id":"e0e512f8-e260-4b1a-a840-11edabb50e26","MimeType":"application/pdf","FileName":"ID927 afamelanotide chair presentation to PM for projector and public [redacted].pdf","Length":452230,"Hash":"7D9FD12941E1BE426C0021680A0AABD6C5057CB7","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"1-2","ConsultationDocumentId":0}},"ETag":null,"Title":"Public committee slides","Level":1,"PublishedDate":"2018-05-22T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":104,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-evaluation-determination-document"}]},"ETag":null,"Id":"9a759999-51d9-4c43-8712-46bf1e28dd73","MimeType":"application/pdf","FileName":"ID927 afamelanotide EPP FED [noACIC].pdf","Length":375069,"Hash":"C7DA5EE899F23F3EA6661EEB44842189B0E7785B","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-evaluation-determination-document","ConsultationDocumentId":0}},"ETag":null,"Title":"Final evaluation determination document","Level":1,"PublishedDate":"2018-05-22T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":104,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Final evaluation determination","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/committee-papers-2"}]},"ETag":null,"Id":"c30e1a23-7e2d-46bf-b82b-ba37fa69041c","MimeType":"application/pdf","FileName":"ID927 afamelanotide_FED_CmtePprs.pdf","Length":5259175,"Hash":"5BED000E54AA369CAD24693F3E272E0674C6F9BD","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"committee-papers-2","ConsultationDocumentId":0}},"ETag":null,"Title":"Committee papers","Level":1,"PublishedDate":"2018-05-22T00:00:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":104,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Final evaluation determination","PanelType":"Evidence","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/html-content"}]},"ETag":null,"Id":"b100b56a-8b23-4fd8-89e2-62393ac0c04a","MimeType":"text/html","FileName":"HtmlContent","Length":3469,"Hash":"49732F7E802118BD710B36B73E5525523D744160","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"html-content","ConsultationDocumentId":0}},"ETag":null,"Title":"Evaluation consultation: 1","Level":1,"PublishedDate":"2017-12-22T13:16:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/1"}]},"ETag":null,"Id":"e0f018cd-bb5a-48c2-a59a-0741873dbfc2","MimeType":"application/pdf","FileName":"ID927 afamelanotide committee slides.pdf","Length":297097,"Hash":"9A84F620E89F88B30E36D016EAB1138BF3C5C63A","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"1","ConsultationDocumentId":0}},"ETag":null,"Title":"Public committee slides","Level":1,"PublishedDate":"2017-12-20T00:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/evaluation-consultation-document"}]},"ETag":null,"Id":"81392926-dbe6-49b3-bae8-2b316c27942b","MimeType":"application/pdf","FileName":"ID927 afamelanotide ECD.pdf","Length":400620,"Hash":"C48ECE78E8ACAFC70C2A35CDC50EBFDB4270F66C","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"evaluation-consultation-document","ConsultationDocumentId":0}},"ETag":null,"Title":"Evaluation consultation document","Level":1,"PublishedDate":"2017-12-20T00:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/committee-papers"}]},"ETag":null,"Id":"7919b61c-031c-407f-8d15-8043bad3c30f","MimeType":"application/pdf","FileName":"ID927 afamelanotide committee papers.pdf","Length":8427415,"Hash":"0ADADAB4799F8BE39E3D0564F20EB047F0220B83","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"committee-papers","ConsultationDocumentId":0}},"ETag":null,"Title":"Committee papers","Level":1,"PublishedDate":"2017-12-20T00:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Evaluation consultation: 1","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/committee-papers"}]},"ETag":null,"Id":"7919b61c-031c-407f-8d15-8043bad3c30f","MimeType":"application/pdf","FileName":"ID927 afamelanotide committee papers.pdf","Length":8427415,"Hash":"0ADADAB4799F8BE39E3D0564F20EB047F0220B83","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"committee-papers","ConsultationDocumentId":0}},"ETag":null,"Title":"Committee papers","Level":1,"PublishedDate":"2017-12-20T00:01:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Evaluation consultation: 1","PanelType":"Evidence","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"ETag":null,"HasResources":false}},"ETag":null,"Title":"Committee meetings","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource-list":{"_links":{"self":[{}]},"_embedded":{"nice.indev:resource":[{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/draft-scope-and-provisional-matrix-comments-table-post-referral"}]},"ETag":null,"Id":"f3f08345-43a4-4842-9607-b389105f66be","MimeType":"application/pdf","FileName":"ID927 Afamelanotide scope comments table 170517 [noACIC].pdf","Length":218267,"Hash":"8FFD31163821575432F08A5F8E426DCC51C112AA","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"draft-scope-and-provisional-matrix-comments-table-post-referral","ConsultationDocumentId":0}},"ETag":null,"Title":"Draft scope and provisional matrix comments table (post-referral)","Level":1,"PublishedDate":"2017-05-17T13:03:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-scope"}]},"ETag":null,"Id":"ca81fd7d-b9ec-4da4-82df-6d3b3abe20f5","MimeType":"application/pdf","FileName":"ID927 Afamelanotide final scope 170517 [noACIC].pdf","Length":85500,"Hash":"068C0CAD3B8E08E7C6D2C3AF6E49B19FED3CA4BD","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-scope","ConsultationDocumentId":0}},"ETag":null,"Title":"Final scope","Level":1,"PublishedDate":"2017-05-17T13:03:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/final-matrix"}]},"ETag":null,"Id":"7781d858-a8a3-4321-8109-0b31f72ba3e8","MimeType":"application/pdf","FileName":"ID927 afamelanotide - final matrix 16052017 [noACIC].pdf","Length":299481,"Hash":"CDDFD25F94E5F37A989BB3C724F2FCBF92F375E7","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"final-matrix","ConsultationDocumentId":0}},"ETag":null,"Title":"Final matrix","Level":1,"PublishedDate":"2017-05-17T13:03:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false},{"_links":{"self":[{}]},"_embedded":{"nice.indev:file":{"_links":{"self":[{"href":"/guidance/GID-HST10009/documents/equality-impact-assessment-scoping"}]},"ETag":null,"Id":"adf45653-7e88-4673-b9ce-6c4257431380","MimeType":"application/pdf","FileName":"ID927 porphyria afamelanotide scoping EIA FINAL.pdf","Length":179698,"Hash":"651FDD02E092B6BBAEE04B40575ECBC916DB5FA8","Name":"default","Reference":"GID-HST10009","ResourceTitleId":"equality-impact-assessment-scoping","ConsultationDocumentId":0}},"ETag":null,"Title":"Equality impact assessment (Scoping)","Level":1,"PublishedDate":"2017-05-30T12:25:00","ExternalUrl":null,"ShowInDocList":true,"TextOnly":false,"ConsultationId":0,"ConsultationDocumentId":0,"IsCurrentViewableConsultationMarkup":false,"ConvertedDocument":false,"SupportsComments":false}]},"ETag":null,"HasResources":true}},"ETag":null,"Title":"Invitation to participate","PanelType":"History","LegacyPanel":false,"OriginalReference":null,"UpdateReference":null,"ShowPanel":true}]},"ETag":null}},"ETag":"01000000-0000-0001-0000-000000000A7F","Summary":null,"Description":null,"ReferralDate":null,"SuspendDiscontinuedReason":"Topic update: this evaluation has not been defined as therapeutically critical. The appraisal was therefore  paused as part of the impact experienced by COVID-19. \r\n\r\nA committee meeting has been scheduled for the 06 July to discuss this topic.","SuspendDiscontinuedUrl":null,"SuspendDiscontinuedUrlText":null,"LegacyModel":false,"ProductReference":null,"EvidenceAssessmentGroup":null,"Reference":"GID-HST10009","ProjectType":"HST","TechnologyType":null,"ProductTypeName":"Highly specialised technology","Process":"HST","Title":"Afamelanotide for treating erythropoietic protoporphyria [ID927]","Status":"ImpactedByCOVID19","ProjectGroup":"Guidance","PublishedDate":null,"LastModifiedDate":"2022-06-22T17:37:43.665842","FirstGoLiveDate":"2017-05-10T10:08:15.4901393","CreatedDate":"2017-05-10T10:00:19.5457066","DevelopedAs":null,"RelevantTo":null,"IdNumber":"927","AreasOfInterestList":[],"TopicSelectionDecision":"Selected","TopicSelectionReason":null,"TopicSelectionDecisionDate":null,"TopicSelectionFurtherInfo":null,"IndicatorSubTypes":[]}